Download full-text PDF |
Source |
---|
Medicine (Baltimore)
September 2024
Department of Gastroenterology, Shaanxi Provincial People's Hospital, Xi'an, China.
Bull Cancer
October 2024
Service d'hématologie clinique et d'oncologie pédiatrique, faculté de médecine et de pharmacie de Casablanca, centre hospitalier universitaire 20 Août de Casablanca, Casablanca, Maroc.
Bone marrow aplasia is a rare and serious hematologic disorder. Although benign, it is a hematologic disorder whose prognosis can be poor and whose spontaneous development can be fatal. Treatment is long, difficult and costly.
View Article and Find Full Text PDFCureus
February 2024
Family Health Unit Cartaxo Terra Viva, Regional Health Administration of Lisbon and Tagus Valley, Cartaxo, PRT.
Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant hereditary disorder. In Portugal, it is mainly linked to transthyretin (TTR) mutation, and patients present with length-dependent sensory-motor polyneuropathy, often accompanied by autonomic dysfunction. Treatment options for FAP include liver transplant, and due to the lack of organs, FAP livers began being implanted in patients with severe liver disease in a process known as domino liver transplantation (DLT).
View Article and Find Full Text PDFFront Cell Infect Microbiol
November 2023
Department of Biomedical Sciences Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China.
is an opportunistic pathogen. Previously reported infections associated with have often been linked to contact with cats, dogs, and other animals. Cases of systemic multiple-site infections following infection are rare.
View Article and Find Full Text PDFInt J Gen Med
March 2023
Department of Clinical and Chemical Pathology, Qena Faculty of Medicine, South Valley University, Qena, Egypt.
Introduction: HCC is frequently diagnosed late, when only palliative treatment is available. So, we try to use different immunological markers to identify early HCC in patients with unremarkable raised AFP.
Methods: This study was conducted on 112 participants divided into two equal groups: Group I, 56 patients with liver cirrhosis and different stages of HCC; Group II, 56 patients with liver cirrhosis.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!